ATE544456T1 - D-mannose-kontrazeptiva - Google Patents

D-mannose-kontrazeptiva

Info

Publication number
ATE544456T1
ATE544456T1 AT02759484T AT02759484T ATE544456T1 AT E544456 T1 ATE544456 T1 AT E544456T1 AT 02759484 T AT02759484 T AT 02759484T AT 02759484 T AT02759484 T AT 02759484T AT E544456 T1 ATE544456 T1 AT E544456T1
Authority
AT
Austria
Prior art keywords
mannose
egg
inhibit
contraceptives
sperm
Prior art date
Application number
AT02759484T
Other languages
English (en)
Inventor
Dale L Benedict
Martha Benedict
Original Assignee
Bio Tech Pharmacal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Tech Pharmacal Inc filed Critical Bio Tech Pharmacal Inc
Application granted granted Critical
Publication of ATE544456T1 publication Critical patent/ATE544456T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02759484T 2001-08-29 2002-08-29 D-mannose-kontrazeptiva ATE544456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31566101P 2001-08-29 2001-08-29
PCT/US2002/027463 WO2003020288A1 (en) 2001-08-29 2002-08-29 D-mannose contraceptives

Publications (1)

Publication Number Publication Date
ATE544456T1 true ATE544456T1 (de) 2012-02-15

Family

ID=23225485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02759484T ATE544456T1 (de) 2001-08-29 2002-08-29 D-mannose-kontrazeptiva

Country Status (10)

Country Link
US (2) US6753319B2 (de)
EP (1) EP1429786B1 (de)
CN (1) CN1578666A (de)
AT (1) ATE544456T1 (de)
AU (1) AU2002324816B2 (de)
CA (1) CA2506944C (de)
ES (1) ES2382242T3 (de)
MX (1) MXPA04002950A (de)
NZ (1) NZ532004A (de)
WO (1) WO2003020288A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1429786B1 (de) * 2001-08-29 2012-02-08 Bio-Tech Pharmacal, Inc. D-mannose-kontrazeptiva
US20050020510A1 (en) * 2002-08-29 2005-01-27 Benedict Dale L. D-mannose contraceptives
US20040147459A1 (en) * 2002-10-23 2004-07-29 Joseph Oneal Method and composition for maintaining urinary tract health in the face of infections
JP4488852B2 (ja) * 2004-09-17 2010-06-23 味の素ゼネラルフーヅ株式会社 体内脂肪低減作用を有する組成物
JP5214978B2 (ja) * 2006-01-24 2013-06-19 味の素ゼネラルフーヅ株式会社 血圧の降下作用及び/または上昇抑制作用を有する組成物およびこれを含有する飲食物
US8063026B2 (en) * 2006-04-06 2011-11-22 Richard Katz Method of palliating lower urinary tract infections by treatment with mannan oligosaccharides
JP4771882B2 (ja) * 2006-07-21 2011-09-14 味の素ゼネラルフーヅ株式会社 糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
US20220105032A1 (en) * 2020-10-07 2022-04-07 Uqora, Inc. Beverage unit and method to provide the beverage unit

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511558A (en) * 1983-05-16 1985-04-16 University Patents, Inc. Alpha-lactalbumin contraceptive
JPH04334320A (ja) * 1991-05-10 1992-11-20 Nakano Vinegar Co Ltd 整腸効果作用組成物
US5994086A (en) 1994-03-30 1999-11-30 North Shore University Hospital Method for assessing infertility by binding of mannose to sperm cells
US5854254A (en) 1994-03-30 1998-12-29 North Shore University Hospital Male contraceptives
US5939279A (en) 1997-09-18 1999-08-17 The Board Of Trustees Of The University Of Arkansas Inhibition of bacterial binding by high-mannose oligosaccharides
EP1429786B1 (de) * 2001-08-29 2012-02-08 Bio-Tech Pharmacal, Inc. D-mannose-kontrazeptiva
US20050020510A1 (en) * 2002-08-29 2005-01-27 Benedict Dale L. D-mannose contraceptives

Also Published As

Publication number Publication date
AU2002324816B2 (en) 2009-09-17
EP1429786B1 (de) 2012-02-08
US20040180839A1 (en) 2004-09-16
CA2506944C (en) 2010-10-12
CN1578666A (zh) 2005-02-09
EP1429786A1 (de) 2004-06-23
WO2003020288A1 (en) 2003-03-13
MXPA04002950A (es) 2005-04-11
CA2506944A1 (en) 2003-03-13
ES2382242T3 (es) 2012-06-06
US20030073643A1 (en) 2003-04-17
EP1429786A4 (de) 2005-12-14
US6753319B2 (en) 2004-06-22
NZ532004A (en) 2006-06-30

Similar Documents

Publication Publication Date Title
MX9300110A (es) Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
HN1997000151A (es) Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.
MX9703868A (es) Inhibidores de cgmp-pde para el tratamiento de disfuncion erectil.
MXPA05005243A (es) Pelicula comestible para el alivio de la tos o sontomas relacionados con la faringitis.
IS4057A (is) Efni til að auka kyngetu
BR0208636A (pt) Agente terapêutico para doenças de artrìtides crÈnicas de doenças relacionadas com inf‰ncia
ATE544456T1 (de) D-mannose-kontrazeptiva
ATE506959T1 (de) Verwendung von il-18 inhibitoren
AR026197A1 (es) Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina
BR9807523A (pt) Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids.
ATE286397T1 (de) Wirkstoff-kombination (z.b. galanthamin oder desoxypeganin mit acamprosat oder memantin) zur medikamentösen sucht- oder rauschmitteltherapie
Ling Buddhist factors in population growth and control: A survey based on Thailand and Ceylon
BR0210543A (pt) Tablete macio de caldo de carne
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
BR9911619A (pt) Pestivìrus atenuados
BR0314787A (pt) Forma de dosagem de liberação modificada
PT1411971E (pt) Utilizacao de pentraxina longa ptx3 para o tratamento de infertilidade feminina
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
WO1996002240A3 (en) Use of inhibitors of human s-cd23
BR0318195A (pt) bainha contraceptiva com construção de rebordo inteiriço
PT1017667E (pt) 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria
NO20003866L (no) Urte-antiviralt middel
Cates How much do condoms protect against sexually transmitted diseases?
MX9401244A (es) Composiciones farmaceuticas.
Hadden An HIV/AIDS prevention intervention with female and male STD patients in a peri-urban settlement in KwaZulu Natal, South Africa